Delic Corp to Present on Company’s Expansion Strategy, Industry Outlook at H.C. Wainwright Conference

May 18, 2022

Matt Stang, Co-founder and CEO of Delic Corp, will share the Company’s strategic targets for the remainder of the year at the H.C. Wainwright Annual Global Life Sciences Conference from May 23-26

Delic Holdings Corp Provides Default Status Update

May 16, 2022

Delic Corp is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders.

Ketamine Wellness Centers (KWC) Announces Partnership With The Veterans Administration (VA) in Arizona

May 12, 2022

Nation’s Largest Ketamine Therapy Provider to Cover Out-Of-Pocket Costs for Veterans Experiencing Treatment-resistant Depression, PTSD and Anxiety

Ketamine Wellness Centers Introduces NAD+ Infusion Therapy

May 4, 2022

KWC Becomes Largest Ketamine Provider in the U.S. to Offer NAD+, Will be Available to Patients at Six Clinic Locations Beginning May 9


May 3, 2022

Delic Corp’s annual financial statements and accompanying management’s discussion and analysis for the fiscal year ended December 31, 2021 are not expected to be finalized by May 2, 2022, The Company has applied for a management cease trade order.

Delic Corp to Discuss Business Expectations, Growth Opportunities at Planet MicroCap Showcase

April 28, 2022

Hosted in Las Vegas, Nevada, the Planet MicroCap Showcase is the premier in-person MicroCap finance event. At this year’s showcase, Stang will deliver a presentation highlighting the Company’s development and outlook for the second half of the year.

Delic Corp to Participate at Sequire Cannabis and Psychedelic Conference and Scottsdale Capital Event

April 19, 2022

Matt Stang, Co-founder and CEO of Delic Corp, will present on the Company’s strategic outlook for the remainder of the year at the Sequire Cannabis and Psychedelic Conference on April 20, 2022 and the Scottsdale Capital Event on April 22-24, 2022.

Delic Labs Receives Health Canada 56 Exemption to Conduct Research on MDMA, LSD and Other Psychedelic Compounds

April 13, 2022

Federally-licensed research lab received additional 56 Research Exemption to acquire psilocybin mushrooms from Nectar Health Sciences Laboratory Division Inc.

Delic Expansion Accelerating into 2022 with New Clinic Openings

March 31, 2022

Ketamine Wellness Centers (KWC) Opens Locations in Salt Lake City and Reno with More on the Way, Adds FDA-Approved SPRAVATO® to Treatment Options

Ketamine Wellness Centers (KWC) Expands Treatment Options with Introduction of SPRAVATO® Nasal Spray

March 30, 2022

FDA-Approved Spray Treatment Ensures KWC Will Now Serve More Patients than Any Other Ketamine Provider in the U.S. with the Addition of SPRAVATO, Beginning April 1

Delic Corp uses cookies to
ensure you get the best experience
on our website. View our Privacy
Policy for more information.